Coptis Enters AI Race with 'Purple' Prompt-to-Formula Agent

Coptis unveils 'Purple,' an AI formulation tool using a secure 'walled garden' approach to protect client data, challenging in-house and supplier-led AI.

At a Glance: French software provider Coptis has unveiled two AI-powered tools, 'Purple' and 'Document Reader', designed to accelerate cosmetic formulation and ensure regulatory compliance from the outset [1] [3] [4]. The system uses a client's own proprietary data rather than external AI models, positioning it as a secure 'copilot' for R&D teams in a market seeing growing competition from in-house platforms at major brands and supplier-specific assistants [1] [13] [18].

Coptis Unveils 'Purple' AI to Accelerate Formulation

At its annual User Club event in Paris on October 13, 2026, software provider Coptis unveiled two new artificial intelligence tools [1] [3] [4] [11] [17]. With over 27 years of experience in cosmetic R&D software, the company introduced 'Purple,' a 'Prompt-to-Formula' AI agent, and 'Document Reader,' a data extraction tool [1] [4]. These new modules are designed to support R&D, formulation, innovation, and regulatory affairs teams [3] [6].

The 'Purple' agent is engineered to transform a marketing brief or an INCI list into a compliant cosmetic formula by leveraging a company's existing R&D knowledge [1] [2] [3] [4] [10] [12] [20]. It works in tandem with 'Document Reader,' which automates the creation of raw material records by extracting data from supplier documents, usually in PDF format [1] [2] [3] [4] [11] [12] [17]. Coptis states that the goal is to help brands, manufacturers, and laboratories accelerate innovation, personalize products, and maintain compliance amid a tightening regulatory landscape [1] [3]. The launch event gathered industry representatives to demonstrate these new capabilities [3] [4] [17].

With Purple and Document Reader, we’re putting AI to work for formulation and regulatory experts—to save them time without ever compromising on reliability and compliance. [10]

A 'Walled Garden' Strategy: How the AI Works

Coptis's strategy for Purple rests on three pillars: 'Prompt-to-Formula,' 'Compliance by Design,' and 'Native to Coptis' [2] [4] [10] [20]. The 'Native to Coptis' approach is central to its value proposition. The AI operates exclusively on a client’s proprietary raw materials data and the Coptis knowledge base, creating a secure 'walled garden' [1] [2] [4] [10] [12] [20]. This model deliberately avoids external, general-purpose Large Language Models (LLMs) to, as Coptis argues, ensure data security and reliability [1] [12] [20].

The Document Reader tool fuels this closed system by converting unstructured data into a usable format [1]. It reads supplier PDFs and automatically populates raw material records with key data points, including INCI composition, traces, and natural origin indicators under ISO 16128 and COSMOS standards [1] [2] [4] [11] [17]. The system then cross-checks extracted values against the customer’s specific settings and Coptis's own reference data for properties, solubility, and alerts [4] [11]. Planned enhancements include source traceability that will display the page number and original passage for each extracted data point [2] [10].

The AI Arms Race in Cosmetic R&D

The launch of Purple positions Coptis within a broader industry trend of adopting AI to accelerate R&D, though strategies vary significantly [13] [18]. Some of the largest players are developing proprietary, in-house solutions. L'Oréal, for example, recently expanded its partnership with Nvidia to build a powerful AI engine dedicated to rapid formulation discovery [18].

Another approach is emerging from the supply side of the industry [13]. Specialty ingredient supplier Grant Industries recently launched 'Albert,' an AI-powered formulation assistant designed to support customers using its specific portfolio of raw materials [13]. As a third-party software provider, Coptis offers a different model: a platform-based tool that integrates with a client's existing multi-supplier data and internal know-how, rather than being tied to a single brand or ingredient catalog [1] [12].

Formulating Under the Watch of Regulators

Coptis is heavily marketing Purple's ability to operate as a regulatory 'copilot' through its 'Compliance by Design' pillar, which integrates regulatory checks from the very first draft of a formula [2] [4] [10] [20]. This feature is critical as formulators navigate an increasingly complex global regulatory landscape, including the EU's Cosmetics Regulation 1223/2009 and the US Modernization of Cosmetics Regulation Act (MoCRA) [13].

The broader regulatory framework for AI itself is also taking shape [15]. The EU AI Act, which entered into force in August 2024, may classify AI systems used in cosmetic safety assessment as 'high-risk' under its Annex III provisions [15]. However, AI adoption does not change fundamental compliance obligations [15]. The toxicological data requirements for cosmetic product safety dossiers under EU Regulation 1223/2009 remain the same, regardless of whether a formula was discovered using AI [15]. Ultimately, human safety assessors remain responsible for the final product, and as of now, no specific INCI convention or ISO label exists to identify AI-generated molecules [15].

Outlook: From Lab Bench to AI Prompt

The emergence of tools like Purple and L'Oréal's AI engine signals a potential shift in the R&D workflow, moving from iterative physical testing to AI-driven candidate screening [18]. This change would allow formulators to reserve costly and time-consuming bench trials for only the most promising compositions identified by the AI [18]. This new paradigm reinforces the critical importance of high-quality, reliable, and structured data, which serves as the essential foundation for any effective AI system [20].

Coptis plans to showcase Purple and Document Reader at the in-cosmetics Asia trade show in Bangkok from November 3-5, 2026 [20]. The company will also host a conference on November 4 titled, “Making AI Reliable in Cosmetic R&D: The Scientific Data Foundation” [20]. The future product roadmap will be guided by user priorities gathered during workshops at the Paris User Club event [7] [17]. While the technology promises to accelerate innovation, a key question for sourcing and R&D professionals remains the current lack of public performance metrics or case studies to validate its efficiency and accuracy.

Key Takeaways

Coptis's 'Purple' AI generates formulas using a client's private data and knowledge base, not external LLMs, addressing data security and intellectual property concerns [1] [2] [4].
The 'Document Reader' tool is a critical enabler, designed to solve the 'garbage in, garbage out' problem by structuring data from unstructured supplier PDFs [1] [2] [11].
The market is seeing three distinct AI strategies emerge: large-scale in-house platforms (L'Oréal), supplier-specific assistants (Grant Industries), and third-party software providers (Coptis) [13] [18].
Despite AI-driven acceleration in R&D, human safety assessors remain legally responsible for product safety, and compliance with regulations like EU 1223/2009 is unchanged [15].
Coptis will demonstrate its new AI tools at in-cosmetics Asia in November 2026, offering the industry a first public look at the technology in action [20].